Q2i / 25B20: Describe the following pharmacology of both unfractionated heparin and bivalirudin

K2iii / 25B19: Outline the following pharmacology of phenytoin

R2i / R1i / 25B18: Define heat, temperature, electrical methods and non electrical methods

R1i / R2i / 25B18: Define heat, temperature, electrical methods and non electrical methods

S1ii / 25B17: Describe the complement system

N1i / 25B15: Explain the role of the liver

T2i / 25B10: Describe the following pharmacology of meropenem

G7ii / 25B09: Compare and contrast the following pharmacology of sodium nitroprusside and glyceryl trinitrate

Q4ii / 25B06: Outline the potential adverse consequences of blood product transfusion

H1vi / 25B04: Outline the physiological effects of end stage renal dysfunction.

Civ / 25B01: Describe how ligands binding to cell membrane receptors can cause a change within that cell

T2ii / 25A20: Fluconazole, amphotericin and caspofungin are anti-fungal drugs

K4ii / 25A19: Describe the intracellular events that occur following opioid receptor activation

R1iv / R1iii / 25A16: Define the Interthreshold range of body temperature

R1iii / R1iv / 25A16: Define the Interthreshold range of body temperature

G4i / 25A12: Outline the structural features of the capillary membrane that facilitate the movement of water

Pi / Pvi / 25A10: With respect to enteral feeds

Pvi / Pi / 25A10: With respect to enteral feeds

G7i / 25A09: Compare and contrast milrinone and dobutamine

Q1i / 25A06: With respect to red blood cell production, outline the following